FOLH1 and posterior cortical atrophy: PSMA-targeted surgery involves using PSMA as a molecular marker to enhance the precision of PCa for an intuitive, fast and reliable way to discriminate PCa tumors from NP tissue, making the outcome of surgery less dependent on the surgeon's own experience and preoperative imaging, visual findings, or frozen sections during surgery.